Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Dobustat price review plea rejected by dept of pharma

Dept of Pharma upholds NPPA Price Cap on Dobustat Injection

Farhat Nasim7 Nov 2024 3:45 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has upheld a decision by the National Pharmaceutical Pricing Authority (NPPA) regarding the price...

Murder of Amravati Chemist a Terror Act, Rules NIA Court, Denies Bail to Accused

Delhi Court slams Pharma company for copycat packaging, issues permanent injunction against its brand

Farhat Nasim6 Nov 2024 4:42 PM IST

"It appears that the defendant has kept the pack of the plaintiff in front while preparing its pack," the court said.

SMS Medical College Neurosurgery HoD caught red-handed accepting bribe of Rs 1 lakh, arrested

Assistant Drug Controller Caught taking Rs 40k bribe to approve pharmacy license, arrested

Farhat Nasim6 Nov 2024 4:39 PM IST

Bengaluru: In a recent case of corruption in Bengaluru, Lokayukta police has nabbed an assistant drug controller while he was accepting a bribe of Rs...

No Entry Without Notice: CDSCO Directs All Drug Shipments Through Notified Ports via ICEGATE

DoP upholds NPPA ceiling price fixation for Azoran 50mg tablet

Farhat Nasim5 Nov 2024 6:10 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has upheld the ceiling price for Azathioprine 50mg tablets, as determined by the National...

Chemist Body up against Swiggy-PharmEasy's 10-Minute Medicine Delivery Model, Seeks DCGI Intervention

Farhat Nasim5 Nov 2024 4:04 PM IST

New Delhi: The All India Organization of Chemists and Druggists (AIOCD) has voiced strong objections to a potential partnership between Swiggy...

Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun Pharma

Sun Pharma alopecia drug Leqselvi launch blocked in US

Farhat Nasim4 Nov 2024 7:05 PM IST

New Delhi: Pharma giant, Sun Pharmaceutical's launch of its specialty drug Leqselvi in the U.S. market is in limbo as the U.S. District Court in...

AYUSH Simplifies Licensing for Drug Manufacturers with New Fee Structure, Details

Farhat Nasim4 Nov 2024 7:03 PM IST

New Delhi: The Ministry of AYUSH has amended the Drugs Rules of 1945 to streamline the licensing process for Ayurveda, Siddha, Sowa-Rigpa, Unani, and...

CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR Data

DoP rejects Glenmark's appeal on price cap of Clotrimazole Cream

Farhat Nasim3 Nov 2024 12:45 PM IST

New Delhi: The Department of Pharmaceuticals has upheld the National Pharmaceutical Pricing Authority's (NPPA) decision on the price cap for...

Pfizer Wysolone DT price challenge denied: DoP upholds NPPA ceiling on Prednisolone Tablets

Farhat Nasim2 Nov 2024 1:00 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has upheld a price ceiling order issued by the National Pharmaceutical Pricing Authority (NPPA) on...

Fludrocortisone 0.2 mg Study Rejected by CDSCO Panel Over Potential Adverse Effects

La Renon's plea to exempt Sodium Valproate from NPPA price cap rejected

Farhat Nasim31 Oct 2024 2:00 PM IST

New Delhi: The Department of Pharmaceuticals (DoP), functional under India's Ministry of Chemicals and Fertilizers, has rejected an appeal from La...

Cipla Bommasandra facility gets VAI classification from USFDA

DoP orders NPPA to reassess price of Cipla's Advent, Synclar and Azee drugs

Farhat Nasim30 Oct 2024 6:14 PM IST

New Delhi: The Department of Pharmaceuticals (DoP), under the Ministry of Chemicals & Fertilizers, has issued orders to the National...

Severe risk with import of second hand CT scanners, MRI machines, surgical robots, warns industry body, files PIL

Farhat Nasim27 Oct 2024 12:30 PM IST

New Delhi: Medical device manufacturers in India are sounding alarms over the unregulated import of refurbished medical devices, emphasizing serious...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok